Summary: Roche expanded its cobas pro integrated solutions with the introduction of the cobas c 703 and cobas ISE neo analytical units, enhancing high-volume laboratory efficiency and automation.


  1. Enhanced Laboratory Efficiency: The new cobas c 703 and cobas ISE neo units are designed to significantly increase testing throughput—up to 2,000 and 1,800 tests per hour respectively—addressing challenges such as staff shortages and space limitations in high-volume laboratories.
  2. Advanced Automation and Integration: By integrating these units into the cobas pro platform, Roche aims to set a new standard in high-volume clinical chemistry and immunochemistry testing, reducing the need for manual intervention and improving workflow efficiency.
  3. Environmental and Operational Benefits: The cobas ISE neo unit, in particular, enhances ion-selective electrode testing efficiency and reduces the frequency of reagent bottle changes, thereby minimizing plastic waste and logistical burdens, contributing to more sustainable laboratory operations.

Roche launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in countries accepting the CE mark. 

Cobas Pro Integrated Solutions

The cobas pro integrated solutions is a scalable and modular diagnostic platform designed for high-volume laboratories. The cobas c 703 and cobas ISE neo analytical units offer cutting-edge features to help address some of the key challenges faced by diagnostic laboratories worldwide such as shortage of qualified staff and space limitations.

“Today more than ever, accurate and timely diagnostics is critical for effective delivery of healthcare. Labs are under increasing pressure to process more samples, at greater speed without compromising on accuracy,” says Matt Sause, CEO of Roche Diagnostics. “With the launch of the cobas c 703 and cobas ISE neo, we are taking our latest generation clinical chemistry and immunochemistry platform, the cobas pro integrated solutions, to the next level. By integrating high-volume clinical chemistry testing and increased automation, we will set a new standard for high volume testing in the clinical lab.”

Further reading: Digital Pathology Solution from Roche Receives FDA Clearance

Cobas c 703 analytical unit

The new cobas c 703 analytical unit is designed to double the clinical chemistry throughput on cobas pro integrated solutions, offering up to 2,000 tests per hour and 70 reagent positions, the company says. This increased onboard reagent capacity means more high-value tests can be performed whilst improving workflow efficiency and saving time spent reloading reagents. This new unit will minimize operator maintenance to once a month, increasing uptime for laboratories.

Cobas ISE neo analytical unit

The cobas ISE neo is designed to improve ion selective electrode (ISE) testing efficiency, offering up to 1,800 tests per hour, according to Roche. With a number of innovative hardware and software features, including an automated calibration concept, it significantly reduces the need for manual intervention. It also performs more tests per reagent bottle, reducing the frequency of bottle changes, minimizing plastic waste, and reducing logistical efforts compared to previous generation systems.